Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04205227 |
| Title | ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | ENB Therapeutics, Inc |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Cedars Sinai-The Angeles Clinic | Los Angeles | California | 90025 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| Border Medical Oncology | Albury | New South Wales | 2640 | Australia | Details | |
| Blacktown Oncology | Blacktown | New South Wales | 2148 | Australia | Details | |
| Kinghorn-St Vincent's Hospital | Darlinghurst | New South Wales | 2010 | Australia | Details |